All News

RSV Vaccine Uptake Low Among Eligible Populations: Daily Dose
May 07, 2025

Your daily dose of the clinical news you may have missed.

Foluso Fakorede, MD: Racial Disparities in PAD Amputation Rates
May 06, 2025

Rates of amputation in Black Americans with peripheral arterial disease are 3-times higher than that of their White counterparts. Dr Fakorede, discusses, here.

Fremanezumab Demonstrates Dual Benefits in Adults with Migraine and Depression
May 06, 2025

New data from UNITE study suggest fremanezumab was effective in alleviating migraine and comorbid MDD in patients with both conditions.

Stool-Based Testing for Colorectal Cancer Screening is On the Rise: Expert Perspective with Mark Fendrick, MD
May 06, 2025

The increase in stool-based CRC testing is a logical trend, Hendrick said in an interview, given the convenience plus the 2 million younger adults now eligible for screening.

Identifying HPV Types: Preventing Over Treatment and Under Treatment
May 06, 2025

An interview with Jeff Andrews, MD, FRCSC, of BD Life Sciences.

Stark Regional Disparities in US Life Expectancy Trends Revealed in Comprehensive Birth Cohort Analysis
May 06, 2025

Life expectancy increased steadily in the US West and Northeast across the 20th century, but gains were just minimal in Southern states, according to the findings.

Pertussis: A Brief Backgrounder for Primary Care
May 06, 2025

Cases of whooping cough in the US more than doubled in 2024, and 2 infants have died from the infection. Here is background on the infection and vaccine.

One in 5 US Adults Chooses Against Handwashing, Some Citing it as "Unnecessary," National Survey Finds
May 05, 2025

While 20% of US adults choose not to wash their hands at appropriate times, nearly half admitted to forgetting to do it, according to a new national survey.

Fecal Microbiota Treatment via Colonoscopy Safe, Effective for Recurrent C. Diff, Study Suggests
May 05, 2025

DDW 2025. Colonoscopic delivery of fecal therapy prevented recurrent C. diff infection in 95% of participants for 8 weeks, with mild GI adverse events reported by

BD Onclarity Added to ASCCP Guidelines: What It Means
May 05, 2025

An interview with Jeff Andrews, MD, FRCSC, of BD Life Sciences.